Pfizer Inc. (NYSE:PFE) stock closed at $27.11 at the end of the trading session on February 14. The 52-week price range is $25.76 and $43.37, On January 30, the pharma giant released its earnings for the year ending December 31, 2023. During fiscal 2023, the company returned $9.2 billion to shareholders in the form of dividends, or $1.64 per share. Pfizer currently pays a quarterly dividend of $0.42 per share, equating to $1.68 per share annually and giving its stock a yield of about 6.20% based
Pfizer Inc. (NYSE:PFE) closed at $26.57 at the end of trading on Feb. 6. In the preceding 52 weeks, the stock price fluctuated between a low price of $25.76 to a high price of $44.33. On Jan. 30, the pharmaceutical and biotechnology company released its earnings for the year ending Dec. 31, 2023. During fiscal 2023, the company returned $9.2 billion to shareholders in the form of dividends, or $1.64 per share. Based on its current quarterly dividend of $0.42 per share, the annualized dividend di
Looking to supplement your income with The Pfizer (NYSE:PFE) dividends? Aiming for $500 monthly? Here’s how much you need to invest. Pfizer's Financial Snapshot As of Jan 22, Pfizer's shares were trading at $28.31. The company, with a market cap of $160 billion experienced a 52-week range between $45.11 and $25.76. Analyzing Pfizer's Dividend Payouts During the third quarter of 2023, Pfizer announced a dividend of $0.41 per share, a slight increase from $0.40 in the same period of 2022. The tota
The Dow Jones index closed higher by around 25 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Pfizer Inc. (NYSE: PFE) shares closed almost flat on Friday, but lost around 44% during 2023. Pfizer recently announced the completion of its acquisition of Seagen Inc (NASDAQ: SGEN) for $229 per share at a total value of approximately $43 billion. Pfizer recently provided its full-year 2024 guidance, which includes the expected financial impact from the Seagen transaction. For FY24, the pharma giant expects revenue of $58.5 billion-$61.5 billion, including the expected contribution from the Sea